(Q55076951)

17 June 2018

title

Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection. (English)

1 reference

17 June 2018

1 reference

T Isobe

1

1 reference

17 June 2018

K Hiyama

2

1 reference

17 June 2018

Y Yoshida

3

1 reference

17 June 2018

Y Fujiwara

4

1 reference

17 June 2018

M Yamakido

5

1 reference

17 June 2018

publication date

1 December 1994

1 reference

17 June 2018

number of pages

7

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

17 June 2018

volume

85

1 reference

17 June 2018

issue

12

1 reference

17 June 2018

page(s)

1240-1246

1 reference

17 June 2018

The molecular biology of lung cancer pathogenesis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

The rapid detection of unknown mutations in nucleic acids.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

P53 in tumour pathology: can we trust immunocytochemistry?

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

The relationship of p53 immunostaining to survival in carcinoma of the lung

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Accumulation of p53 protein correlates with a poor prognosis in human lung cancer

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919395

Increased expression of mutant forms of p53 oncogene in primary lung cancer

18 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1994.TB02936.X

Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group

21 January 2018

1 reference

12 December 2020

Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer

1 reference

12 December 2020

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

1 reference

12 December 2020

Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung

1 reference

12 December 2020

ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis

1 reference

12 December 2020

Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients

1 reference

12 December 2020

p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking

1 reference

12 December 2020

An improved method for the detection of genetic variations in DNA with denaturing gradient gel electrophoresis

1 reference

12 December 2020

Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameter

1 reference

12 December 2020

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma

1 reference

12 December 2020

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

12 December 2020

Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study

1 reference

12 December 2020

Prognosis and survival in resected lung carcinoma based on the new international staging system

1 reference

12 December 2020

Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer

1 reference

12 December 2020

p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes

1 reference

12 December 2020

10.1111/J.1349-7006.1994.TB02936.X

Identifiers

DOI

1 reference

17 June 2018

PMC publication ID

5919395

1 reference

17 June 2018

PubMed publication ID

7852188

1 reference

17 June 2018